ArticleSignal transduction and targeted therapy2025

Rapavir, a novel inhibitor of sodium taurocholate cotransporting polypeptide, potently blocks hepatitis B virus entry.

Jia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.